Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine
Clinical Pharmacology & Therapeutics · 2024
DOI: 10.1002/cpt.3198 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von Qi Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: United States Food and Drug Administration, Silver Spring, Maryland, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Pharmacology, Clinical. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- United States Food and Drug Administration, Silver Spring, Maryland, USA.
- Genentech Inc., South San Francisco, California, USA.
- Great Ormond Street Institute of Child Health, University College London, London, UK.
- Certara, Canterbury, UK.
- Leiden University, Leiden, The Netherlands.
ORCID-Profile: Qi Liu, Amita Joshi, Joseph F Standing
Zitieren
APA
Liu, Q., Joshi, A., Standing, J. F., & van der Graaf, P. H. (2024). Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3198
Vancouver
Liu Q, Joshi A, Standing JF, van der Graaf PH. Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3198
BibTeX
@article{Liu2024,
author = {Liu, Qi and Joshi, Amita and Standing, Joseph F and van der Graaf, Piet H},
title = {Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine},
journal = {Clinical Pharmacology & Therapeutics},
year = {2024},
doi = {10.1002/cpt.3198}
}
EUVIMED